F. Shanahan

National University of Ireland

Health Outcomes Studied

• Increased Fecal Propionic Acid Levels
• Reduced Abdominal Pain
• Reduced Colitis-Related Mortality
• Reduced Flatulence
• Reduced Straining

Papers (14)

• 2022
  Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial.10.3920/BM2021.0173
• 2019
  Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.10.1053/j.gastro.2019.05.008
• 2017
  Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat10.1038/srep43300
• 2013
  Bifidobacterium infantis suppression of Peyer's patch MIP-1α and MIP-1β secretion during Salmonella infection correlates with increased local CD4+CD25+ T cell numbers.10.1016/j.cellimm.2013.03.008
• 2013
  Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut10.4161/gmic.25487
• 2012
  Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota.10.3945/ajcn.111.026435
• 2012
  Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production.10.1152/ajpgi.00003.2012
• 2009
  Exploring the Diversity of the Bifidobacterial Population in the Human Intestinal Tract10.1128/AEM.02216-08
• 2006
  Efficacy of an Encapsulated Probiotic Bifidobacterium infantis 35624 in Women with Irritable Bowel Syndrome10.1111/j.1572-0241.2006.00734.x
• 2006
  Multireplicon genome architecture of Lactobacillus salivarius.10.1073/PNAS.0511060103
• 2005
  Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.10.1053/J.GASTRO.2004.11.050
• 2005
  Correlation of probiotic Lactobacillus salivarius growth phase with its cell wall-associated proteome.10.1016/J.FEMSLE.2005.08.051
• 2001
  Probiotic impact on microbial flora, inflammation and tumour development in IL‐10 knockout mice10.1046/j.1365-2036.2001.01027.x
• 2001
  In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.10.1093/ajcn/73.2.386s